JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study

Clinical trial NCT06412848 · COMPLETED

Trial details

NCT number: NCT06412848
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Study type: OBSERVATIONAL

Urothelial Carcinoma

Start date: 2024-05-09
Primary completion: 2026-06-30
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.